Literature DB >> 24203930

Imatinib therapy in a patient with suspected chronic neutrophilic leukemia and FIP1L1-PDGFRA rearrangement.

Nitin Jain1, Joseph D Khoury, Naveen Pemmaraju, Praveen Kollipara, Hagop Kantarjian, Srdan Verstovsek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24203930     DOI： 10.1182/blood-2013-07-516500

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia.

Authors:  Shilpan Shah; Sanam Loghavi; Guillermo Garcia-Manero; Joseph D Khoury
Journal:  J Hematol Oncol       Date:  2014-03-27       Impact factor: 17.388
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.